Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Size

Magnum Research fires off $30m round
Alibaba and Lenovo both took part in a series B round for the digital wealth manager incubated at Hong Kong University of Science and Technology.
AavantiBio activates with $107m
Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.
SparingVision sees to new funding
Incubated by Vision Institute, the retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises.
NetScientific picks up ProAxsis
QUB spinout ProAxsis has been fully acquired by NetScientific, which previously backed the company’s sole funding round in 2014.
Daily deal net: October 22, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Astellas takes an Iota in acquisition deal
The UC Berkeley spinout has been snapped up by Astellas, two years after the latter took part in its series A round.
JDSC jumps to series B funding
Utec was among the backers that helped University of Tokyo spinout Japan Data Science Consortium complete a $27.5m round.
Topas tackles $26m series B
Topas Therapeutics, which is exploiting University of Hamburg research, has pocketed $26m in its series B round.

News Continued

V2Food dishes up $55m series B
Main Sequence Ventures, which co-founded the meat-free burger producer last year, has returned for a $55m series B round.
Viontech invites Jinmao to series C round
The computer vision chip producer is based on research at Tsinghua University and Chinese Academy of Sciences.
Disarm hands itself to Eli Lilly
Eli Lilly will acquire the WUSTL-linked neurological disease therapy developer in a $135m deal that could top $1.2bn with milestone payments.
Nanofilm rolls towards stock market
NTU spinout Nanofilm Technologies has seemingly filed a draft prospectus with a view of listing on the domestic Singapore Stock Exchange.
Daily deal net: October 16, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Codiak Biosciences cracks IPO code
Codiak – based on research at Gothenburg and MD Anderson Cancer Center – has succeeded in going public after previously cancelling plans.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg

Login